These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29197260)

  • 1. Susceptibility of dendritic cells from individuals with schistosomiasis to infection by Leishmania braziliensis.
    Lopes DM; de Almeida TVVS; de Souza RDP; Ribeiro LEV; Page B; Fernandes JS; Carvalho EM; Cardoso LS
    Mol Immunol; 2018 Jan; 93():173-183. PubMed ID: 29197260
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Lopes DM; Oliveira SC; Page B; Carvalho LP; Carvalho EM; Cardoso LS
    Front Immunol; 2018; 9():3122. PubMed ID: 30687325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.
    Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O
    Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell profile induced by Schistosoma mansoni antigen in cutaneous leishmaniasis patients.
    Lopes DM; Fernandes JS; Cardoso TM; Bafica AM; Oliveira SC; Carvalho EM; Araujo MI; Cardoso LS
    Biomed Res Int; 2014; 2014():743069. PubMed ID: 25309922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses.
    Vargas-Inchaustegui DA; Xin L; Soong L
    J Immunol; 2008 Jun; 180(11):7537-45. PubMed ID: 18490754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease.
    Brelaz MC; de Oliveira AP; de Almeida AF; de Assis Souza M; Medeiros ÂC; de Brito ME; Pereira VR
    Parasite Immunol; 2012 Apr; 34(4):236-9. PubMed ID: 22394223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis.
    Salhi A; Rodrigues V; Santoro F; Dessein H; Romano A; Castellano LR; Sertorio M; Rafati S; Chevillard C; Prata A; Alcaïs A; Argiro L; Dessein A
    J Immunol; 2008 May; 180(9):6139-48. PubMed ID: 18424735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
    PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
    Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE
    Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
    Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
    PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.
    Costa DL; Carregaro V; Lima-Júnior DS; Silva NM; Milanezi CM; Cardoso CR; Giudice Â; de Jesus AR; Carvalho EM; Almeida RP; Silva JS
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e965. PubMed ID: 21390155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3
    Ferraz R; Cunha CF; Pimentel MIF; Lyra MR; Pereira-Da-Silva T; Schubach AO; Da-Cruz AM; Bertho AL
    Parasit Vectors; 2017 May; 10(1):219. PubMed ID: 28468680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T cell activation by B cells in human Leishmania (Viannia) infection.
    Rodriguez-Pinto D; Saravia NG; McMahon-Pratt D
    BMC Infect Dis; 2014 Feb; 14():108. PubMed ID: 24568275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR2 signaling contributes to the differentiation of protective inflammatory dendritic cells in Leishmania braziliensis infection.
    Costa DL; Lima-Júnior DS; Nascimento MS; Sacramento LA; Almeida RP; Carregaro V; Silva JS
    J Leukoc Biol; 2016 Aug; 100(2):423-32. PubMed ID: 26884611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.
    Costa DL; Guimarães LH; Cardoso TM; Queiroz A; Lago E; Roselino AM; Bacellar O; Carvalho EM; Silva JS
    Hum Immunol; 2013 Dec; 74(12):1491-500. PubMed ID: 23993989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.